Abstract: Administration of estradiol or calcium, or combined, represents the classical therapeutic approach in the treatment of some menopausal symptoms. We have studied the effects of estradiol dipropionate (EDP) and calcium glucoheptonate (Ca) on morphological and hormonal features of the adrenal gland in 14-month-old female Wistar rats. The animals were treated with EDP (0.625 mg/kg b.w.) or Ca (11.4 mg/kg b.w.) daily for two weeks, with control rats receiving vehicle alone by the same schedule. The cell volumes in the zona glomerulosa (ZG) and zona fasciculata (ZF) were 11.2% and 5.5% greater (P<0.05) and in the zona reticularis (ZR) 13.0% smaller (P<0.05) in the EDP group than in the control group. In the Ca group, cell volume in the ZG was increased by 5.6% (P<0.05), while cell volumes in the ZF and ZR were decreased by 26.0% and 14.7%, respectively (P<0.05), in comparison with control values. Serum aldosterone and corticosterone concentrations were higher in the EDP-treated (by 27.8% and 19.8%, respectively) and Ca-treated (by 80.0% and 24.1%, respectively) groups in comparison with the control group (P<0.05). These data suggest that EDP and Ca treatments have stimulatory effects on the ZG and ZF, but inhibitory effects on the ZR in middle-aged female rats. 
Introduction
The hypothalamo-pituitary-adrenal (HPA) system provides defense against stress and tightly integrates the endocrine, nervous and immune systems as a central point [1] . During ageing, the prevalence of cardiovascular diseases, cancer and osteoporosis increases, together with the incidence of stress defense system-related psychiatric disorders, i.e. depression, irritability and sleep disturbance [2] . Significant morphological and functional changes with age may affect the HPA system at different levels. Besides neuronal loss and impaired central regulation of adrenocortical secretion [3] , in advanced age the adrenal cortex has been reported to suffer from degenerative fibrotic changes, loss of steroid-containing lipids, mitochondrial fragmentation, vascular dilatation and hemorrhage [4, 5] .
In menopausal and postmenopausal women, estradiol is widely applied for the prevention of health problems due to ovarian hormone deficiency [6] . Moreover, ovariectomy has been shown to reduce stress-induced secretion of adrenocorticotrophic hormone (ACTH) and corticosterone, which can be reversed with estrogen application [7] . Furthermore, estradiol treatment was found to increase ACTH and corticosterone secretion generally in females [7, 8] , the latter also in gonadectomised male mice [9] . Conversely, estrogen treatment reduces fear related behaviors [10] . Some evidence indicates that estrogen directly influences cellular activity and gene expression via estrogen receptors within the corticotrophin-releasing hormone (CRH) neurosecretory neurons [11] .
Augmented activity of the HPA system in advanced age is associated with high levels of circulating glucocorticoids [5] , long ago documented to induce bone decalcification [12] . Such evidence recommends calcium administration for therapeutic purposes during ageing. Extracellular Ca 2+ is critical for the secretory activity of many neuroendocrine and endocrine cells [13] . Namely, arginine vasopressin (AVP) stimulates ACTH release by a mechanism dependent on extracellular calcium concentration [14] . Also, increasing extracellular calcium stimulates aldosterone secretion [15] .
Considering that significant morphofunctional changes affect the stress defense system during ageing, the aim of this study was to evaluate the extent of alterations to three adrenocortical zones (zona glomerulosa -ZG, zona fasciculata -ZF and zona reticularis -ZR) in middle-aged female rats, after chronic treatment with therapeutical agents i.e. estradiol dipropionate and calcium glucoheptonate. 
Experimental Procedures

Animal treatment
Light microscopy and histological analyses
Left adrenal glands were excised, fixed in Bouin's solution, embedded in pa ra f fin and serially cut into 5 mm thick sections which were stained with hema toxy lin-eo sin for examination under a light microscope (Leica, Germany).
Digital images of adrenal glands were made using a Leica DM RB Photo Microscope (Leica, Wetzlar, Germany), a JVC TK 1280E Video Camera (Leica) and the Qwin program (Leica).
Stereological and morphometric analyses
Stage 1. Zonation of the adrenal gland
In order to evaluate the volume den si ties of the adrenocortical zones, every 10th section of the gland was analyzed using the M 42 multipurpose test system [16] at 125X magnification. The absolute vo lu me of the glands was calculated on the basis of their weight, assuming 1.039 g cm -3 as the ave ra ge specific gravity of the adrenal [17] .
Stage 2. Size and number of adrenocortical cells
The volume densities of both the nuclei and the cytoplasm of parenchymal cells were estimated using the M 42 multipurpose test system [16] at 1000X magnification. For each ad re nal gland, a single paraffin section containing zona medullaris was chosen and 30 test areas of ZG and 50 test areas of ZF and ZR were analyzed. Based on earlier ka ryometric studies [18] , the shape coefficient β was assumed to be 1.382 for the ZF and ZR, and 1.500 for the ZG. It relates N v (number of cells counted per unit volume) to N a (number of cells counted per mm 2 ) and V v (volume density) and de pends on the axial ratio of the estimated nuclei. The number of adrenocortical cell nu clei per mm 3 was calculated according to the method of Weibel and Gomez [19] . Since rat adrenocortical cells are mononuclear, the numerical density of the nuclei cor res ponds to the number of cells per mm 3 .
Serum hormone assays
Blood samples were collected from the trunk after decapitation. The separated serum samples were stored at -20°C until hormone concentrations were determined in duplicate within single assays, respectively, as follows: aldosterone concentration by enzyme immunoassay for direct quantification (Aldosterone ELISA, IBL Hamburg, Germany) with an intra-assay CV of 4.1% (128.61 pg/ml); corticosterone concentration by immunoassay (R&D Systems Inc., Minneapolis, USA) with an intra-assay CV of 8.0% (171 ng/ml) [20] .
Statistical analyses
Statistica ® version 5.0 (StatSoft, Inc) was used for all statistical analyses. Stereological, morphometric and biochemical data obtained for the experimental groups were subjected to one-way analyses of variance (ANOVA). Duncan's multiple range test was used for post hoc comparisons between groups. A confidence level of P<0.05 was considered statistically significant. The data are presented as means ± SD. Regression analysis provided the correlation between the average volume of zones and the average number of cells.
Results
Body weight, absolute and relative weight of the adrenal gland
In female rats treated with EDP or Ca, body weight was 9.0% lower than in the controls in both cases (P<0.05).
The absolute adrenal weights were not significantly (P>0.05) different from control values in either of the treated groups. The relative adrenal weight was increased by 8.1% (P<0.05) in the EDP treated group, in comparison to that for the control rats (Table 1) .
Histological analysis of the adrenal cortex
Three cortical zones were clearly visible in all examined adrenal gland preparations ( Figure 1A-I) . The ZG was arranged in closely packed ovoid clusters with relatively Figure 1A) . In animals treated with EDP or Ca the shape of ZG cells was not significantly different, but the cytoplasm was paler than in the controls ( Figure 1B,C) . The ZF was large with polyhedral cells arranged in long straight cords, one or two cells thick, and separated by sinusoidal capillaries. In control rats this zone possessed both light and heavily stained cells ( Figure 1D ). In rats treated with EDP or Ca, the ZF had longer cells with lighter cytoplasm (Figure 1E,F) . The cells of the ZR in control rats were noticeably smaller than those of the ZF and their nuclei were more deeply stained ( Figure 1G ). In animals treated with EDP or Ca, the ZR cells were arranged in anastomosing cords with few lipid droplets, while dark cells had abundant large pigment granules and deeply staining nuclei. The cells in this zone were smaller as they had less cytoplasm than cells in the ZF. Thus the nuclei appeared more closely packed ( Figure 1H,I ).
Stereological and morphometric parameters of the adrenal cortex
The absolute volumes of the whole adrenal gland and the adrenal cortex in EDP treated rats were increased (P<0.05), by 15.1% and 25.8%, respectively, when compared to values for the control rats (Figure 2) . The absolute and relative volumes of ZG and ZF were larger (P<0.05) in EDP and Ca treated females than in the control rats (Figure 2 and 3) . The absolute volumes of ZR were decreased in EDP-and Ca-treated females, by 9.7% and 39.4% respectively, in comparison with control rat values (P<0.05; Figure 2 ). The relative volume of ZR was 25.0% lower in EDP-treated females and 36.0% lower in Ca-treated females than in the control rats (P<0.05; Figure 3 ).
The total number of cells was increased (P<0.05) in the ZG (by 5.5% in EDP-and 20.6% in Ca treated), and ZF (by 38.9% in EDP-and 41.1% in Ca-treated) when compared to the control values ( Figure 4) . In ZR the total number of cells was lower in both EDP (by 44.2%) and Ca (by 63.7%) groups in comparison to the control females (P<0.05; Figure 4) . Regression analysis showed a positive and statistically significant correlation between the average volume of zones and the average number of cells estimated (r 2 =0.978, P<0.001; Figure 5 ). The volumes of ZG and ZF cells in EDP-treated females were increased by 11.2% and 5.5% respectively, in comparison with the controls (P<0.05; Figure 6 ). In the Ca group, the ZG cell volume was elevated by 5.6% (P<0.05), while the ZF cell volume was reduced by 26.0% (P<0.05), compared to the control values. For the ZR this parameter was significantly decreased (P<0.05) in both EDP and Ca groups, by 13.0% and 14.7% respectively, in comparison to the control animals ( Figure 6 ). 
Hormonal analyses
The serum concentrations of aldosterone and corticosterone were higher (P<0.05) in the EDP-(by 27.8% and 19.8% respectively) and Ca-(by 80.0% and 24.1% respectively) treated groups, compared to values for the control rats ( Figure 7A,B) .
Discussion
Ageing produces serious continuous stress to all organ sys tems, and the most significant age-associated endocrine change is impaired central regulation of the adrenocortical secretion [21] . The aim of our study was to examine the effects of treatment with therapeutic doses of estradiol and calcium on morphofunctional characteristics of the adrenal cortex (the effector component of the HPA system) in middle-aged female rats as an animal model of the menopause.
Our findings clearly demonstrate that multiple doses of EDP or Ca given to middle-aged female rats led to increases of absolute adrenal cortex volume, together with the volumes of ZG and ZF. However, the ZR volume was significantly lower in both treated groups than in the corresponding controls. The higher ZG and ZF volumes resulted from both increased cell numbers (a positive correlation exists) and cell volumes in both zones. The hypertrophy of ZF cells and elevated serum corticosterone may be explained as a consequence of stimulation by ACTH after estradiol application, as previously reported [7, 8] . Estrogen receptor localization within the hypothalamic paraventricular nucleus (PVN) indicates some possible mechanisms of estrogen action: i) central glucocorticoid feedback inhibition [22] and ii) increased CRH neuronal activity [11] followed by a rise in ACTH/corticosterone levels. ACTH, in part, stimulates aldosterone secretion, so ACTH elevation after estradiol application might also have been responsible for the stimulatory changes in the ZG. Rao and Chinoy [23] reported that estradiol inhibits adrenocortical 3βHSD activity, an essential enzyme in steroidogenesis. Conversely, it was observed that estradiol enhances corticosterone secretion in females [7, 24] and gonadoctemized male mice [9] , as well as basal corticosterone secretion in vitro [25] , which our results confirm. It seems legitimate to suggest that the mechanism whereby estradiol enhances corticosterone secretion involves stimulation of cholesterol side-chain cleavage, the rate-limiting step of steroidogenesis [25] . The ZR cells are very sensitive to estradiol treatment. A significant decrease of ZR volume was observed in 60-day old female rats after estradiol treatment [26] , so this finding was expected in our study.
Calcium application for therapeutic purposes during ageing has been operative for decades, but data about its effects on the adrenal cortex are rather scarce. In our study, calcium provoked similar changes to those after estradiol application i.e. morphofunctional stimulation of the ZG and ZF as well as inhibition of the ZR. Increasing extracellular calcium was reported to stimulate the sodium pump and intracellular free calcium concentration rose to the range that stimulates aldosterone secretion [15] . Extracellular Ca 2+ is certainly critical for secretory activity of various neuroendocrine and endocrine cells [13] and a higher level was probably the cause of increased mineraloand glucocorticoid secretion in our work. Namely, AVP stimulates ACTH release by a mechanism dependent on extracellular calcium [14] , so ZG and ZF stimulation may have been mediated by ACTH release in our work. The morphological inhibition of ZR is probably a compensatory process, caused by ZG and ZF stimulation rather than calcium mediated.
In conclusion, this study shows that subcutaneous estradiol and calcium administration in middle-aged female rats stimulated aldosterone and corticosterone secretion. Stereological analysis, in both treated groups, revealed noticeable increases of ZG and ZF volumes, while the same feature of ZR was affected by declining volume and total number of cells, compared to the control group. Essentially, estradiol and calcium, classical therapeutic agents in the protection of some menopause endangered tissues, had visible stimulatory effects on mineralo-and glucocorticoid secretory activity of the female adrenal. This should be considered before and during their therapeutic application. 
References
